Ece Cali, MD, PhD

Thoracic oncologist 🫁 @wustl @sitemancenter via @montefioreNYC @einsteinmed

[IASLC @IASLC]

Thoracic Circle is LIVE! 🎉
A new space to connect, share, and grow with the #IASLC community — anytime, anywhere.
Check your inbox or start here: https://t.co/2nrqbXjwNI

@hivebrite

[Mikkael A. Sekeres MD, MS @MikkaelSekeres]

Announcing the first EVER @JCO_ASCO Art of Oncology Narrative Medicine Contest! 🎉✍️🎗️🩺🎉
We're looking for essays that explore the human experience of cancer and reflect on the experience of trainees and early career hematologists/oncologists. Apply Now! https://t.co/y9ZGiV8uA1

[Ece Cali, MD, PhD @ececalidaylan]

@IvyLorena_Md @ASCO @ASCOPres @NarjustFlorezMD @WomeninOnc @WomenInMedicine @AnaVManana @Latinamd Aw congrats Ivy!! You look gorgeous!

[Ece Cali, MD, PhD @ececalidaylan]

EGFR mutant akciğer kanseri hakkında hem güncel hem de çok keyifli bu sohbeti kaçırmayın @CkapSaadettin #akciğerkanseri #EGFR #onkoloji

[IASLC @IASLC]

Catch the #LungCancerConsidered episode in Turkish! 🇹🇷 Explore first-line therapies for EGFR-mutant NSCLC with @ececalidaylan, Dr. Özden Altundağ & Dr. Saadettin Kiliçkap.

🎧 Listen now: https://t.co/FMeC2j2yB8

[Ece Cali, MD, PhD @ececalidaylan]

@IvyLorena_Md @DartmouthCancer @jennifermarksmd @MomaVelez11 @SamuelKareffMD @jacobadashek @ASCOTECAG @ShrutiPatelMD @jatwanikaran Congrats Ivy! So happy for you 🤗

[Jarushka Naidoo @DrJNaidoo]

#ESMO24 Lung mini-orals🔥

Randomised ph II trial of inhaled corticosteroids in stage III NSCLC treated with cCRT, to reduce radiation pneumonitis:
- 292pts
- 15% reduction in RP
- no long-term steroid tox

No need for ph III, could do tomorrow
#ESMOAmbassadors #ESMO24 @myESMO

[TLC Conference @TLCconference]

The 3rd Annual #TexasLung25 will feature even more faculty than ever before! Mark your calendar to join us April 10-12, 2025 for this 2-day CME/CE meeting in Austin, TX. Be part of the discussions and meet leading thoracic oncologists. #MedEd #LungCancer #CME #CE

[Stephen V Liu, MD @StephenVLiu]

The #WCLC24 Photo Gallery caught some great pics of the incredibly knowledgable contestants on our Meet The Expert Quiz Show! Thanks again to Drs. Natasha Leighl, @bensolomon1 @ececalidaylan @g_mountzios @JessicaJLinMD @zaccoyne and Brinda Gupta!

[Myriam Chalabi @MyriamChalabi]

Honored and excited to be scientific co-chair of #ESMO25 together with @DrChoueiri
With @FAndreMD as incoming @myESMO president on our side we will be giving it our all! See you in #Berlin
🙏 @RebeccaDSing for a fantastic, practice-changing #ESMO24. We learn from the best ❗️❗️

[Ece Cali, MD, PhD @ececalidaylan]

@YatingWang885 Congrats Yating!

[JessicaJLinMD @JessicaJLinMD]

🌟And here with the efficacy and safety data of #NVL655, ALK-selective, TRK-sparing and brain-penetrant 4G ALK TKI, from ALKOVE-1, presented today #ESMO24 by @alexdrilon
✅ ORR 38% in heavily pretreated pts overall (1-5 prior ALK TKIs)
✅ ORR 35% in pts post-lorlatinib (in which setting we currently have no approved ALK TKIs) --> 50-64% in pts with single or compound ALK resistance mutations
✅ ORR 57% in pts lorlatinib-naive

[IASLC @IASLC]

Four leading scientists were honored Saturday at #WCLC24 for their pioneering efforts in thoracic oncology. Read more in #ILCN: https://t.co/P0ghwERrqN @juliebrahmer #LCSM

[Stephen V Liu, MD @StephenVLiu]

Very nice discussion on relapsed #SCLC by Dr. @Arohatgi at #WCLC24. ADCs showing promise and easier to deliver than a BiTE like tarlatamab. No clear biomarker but encouraging efficacy. But we need randomized data to provide clear perspective.

[Rami Manochakian MD, FASCO Cancer Education @RManochakian]

🔥🚨@OncoAlert HOT OFF THE PRESS.

Just presented at the presidential symposium @IASLC #WCLC24

Results of #HARMONi2 trial of
#Ivonescimab VS #Pembrolizumab in advanced non-small cell #LungCancer with PD-L1 >1%.

✅ Significant ⬆️mPFS
11.14 vs. 5.82 months (HR 0.51)

#Benefit in:
✅PD-L1 low (1-49%) & High (>50%)
✅Squamous or Non-Squamous

[Ece Cali, MD, PhD @ececalidaylan]

@BrendonStilesMD @DrSteveMartin Thank you @BrendonStilesMD!

[Ece Cali, MD, PhD @ececalidaylan]

Learning from a mentor indeed never ends, whether it's diving into oncology or savoring Nola food! 🐊 Incredibly lucky to have had Balazs guiding me at the start of my thoracic oncology journey and excited to have him as my first visitor in St. Louis!

[Balazs Halmos @BalazsHalmosMD]

Mentorship 101:
Important to check on your mentees even after they start a new job- like Eçe at Wash U- even if one has to drive 1000+ miles for it!😉
I took the effort to introduce her to new skills, like eating alligator tacos..
Great to see you taking a fantastic start, Eçe!

[Ece Cali, MD, PhD @ececalidaylan]

@Latinamd @DrSteveMartin Thank you, Estela! 💪🏻

[Journal of Clinical Oncology @JCO_ASCO]

#JCO welcomes our onboarding editorial fellows, Ayse Ece Cali Daylan, @MSHughes_MD, Peter Li, Joseph Mathew & @lcshihmd!

[Ece Cali, MD, PhD @ececalidaylan]

@adam_grippin @AACR @ASCO @MDAndersonNews Congrats 🎉

[Ece Cali, MD, PhD @ececalidaylan]

@TansuDaylan So excited for this new phase in our life! 🤗 Thank you all! Çok teşekkürler!